Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lucid Diagnostics (LUCD) Shares Issued (2020 - 2026)

Lucid Diagnostics filings provide 4 years of Shares Issued readings, the most recent being -$43.2 million for Q4 2025.

  • On a quarterly basis, Shares Issued fell 9841.31% to -$43.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$41.2 million, a 2202.86% decrease, with the full-year FY2025 number at $17000.0, down 99.06% from a year prior.
  • Shares Issued hit -$43.2 million in Q4 2025 for Lucid Diagnostics, down from $131000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1.8 million in Q2 2025 to a low of -$43.2 million in Q4 2025.
  • Median Shares Issued over the past 4 years was $141000.0 (2025), compared with a mean of -$3.0 million.
  • Biggest five-year swings in Shares Issued: skyrocketed 25166.67% in 2023 and later tumbled 9841.31% in 2025.
  • Lucid Diagnostics' Shares Issued stood at $1000.0 in 2022, then skyrocketed by 151500.0% to $1.5 million in 2023, then plummeted by 70.78% to $443000.0 in 2024, then tumbled by 9841.31% to -$43.2 million in 2025.
  • The last three reported values for Shares Issued were -$43.2 million (Q4 2025), $131000.0 (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.